Business Card for Scott Klemme:


Associate Director, GMP Services ...
San Diego, CA area
Email Avail: 3 Day Free Trial


1 Dna Way
South San Francisco, CA 94080

Tel: (650) 225-1000

Last updated on 2018-01-12


About Scott Klemme:

Scott Klemme works as an Associate Director, GMP Services ... for Genentech, Inc. at San Diego, CA. The company's webpage is http://www.gene.com. For email, phone number and executive profiles for Associate Director, GMP Services ... and other executives of Genentech, Inc. at San Diego, CA, check Genentech, Inc. at Joesdata.com. Not the Scott Klemme you are looking for? Do a quick search in our website and find other people named Scott Klemme.
Scott Klemme's Work History:
Downstream Process Engineer-Sr. Engineer at Genentech
Downstream Process Engineer-Engineer II at Genentech
Downstream Process Engineer-Engineer I at Genentech
Process Engineer at Seiberling Associates.

Scott Klemme's Education:
University of Wisconsin-Madison.

Scott Klemme's Co-workers:
As of January 20, 2021, Scott Klemme has 1358 co-workers under the company name Genentech, Inc. at Joesdata.com.

About Genentech, Inc.:

Genentech, Inc. is located at 1 Dna Way , South San Francisco, CA 94080. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-13 19:18:41
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-13 17:30:39
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-06 19:24:23
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
2018-08-30 17:30:48
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine
2018-08-13 19:19:15
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-08-13 17:30:37
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-07-25 17:42:26
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-25 17:31:17
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-20 18:54:47
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)
2018-07-20 17:30:51
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)

People in the same industry: